US Patent Issued to VANDERBILT UNIVERSITY on Aug. 11 for "Human IgE monoclonal antibodies to antibodies to alpha-gal (galactose-Alpha-1,3-galactose) and uses therefor" (Tennessee Inventor)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,764, issued on Aug. 11, was assigned to VANDERBILT UNIVERSITY (Nashville, Tenn.).

"Human IgE monoclonal antibodies to antibodies to alpha-gal (galactose-Alpha-1,3-galactose) and uses therefor" was invented by Scott A. Smith (White Bluff, Tenn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure is directed to human IgE antibodies and fragments thereof binding to galactose-Alpha-1, 3-galactose, a known red meat allergen, and methods for use thereof."

The patent was filed on Dec. 13, 2021, under Application No. 18/256,917.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/np...